Kristina Burow's Net Worth

$931 Thousand

Estimate Recalculated Nov 11, 2024 08:51AM EST

Who is Kristina Burow?

Kristina Burow does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Receptos, Inc., Neumora Therapeutics, Inc., DA32 Life Science Tech Acquisition Corp., Gossamer Bio, Inc., Scholar Rock Holding Corp, Erasca, Inc., Verve Therapeutics, Inc., Vir Biotechnology, Inc., Beam Therapeutics Inc., Metacrine, Inc., Unity Biotechnology, Inc., Sienna Biopharmaceuticals, Inc., Prime Medicine, Inc., Boundless Bio, Inc., and Rapport Therapeutics, Inc..

SEC CIK

Kristina Burow's CIK is 0001569248

Past Insider Trading and Trends

2021 was Kristina Burow's most active year for acquiring shares with 11 total transactions. Kristina Burow's most active month to acquire stocks was the month of May. 2015 was Kristina Burow's most active year for disposing of shares, totalling 4 transactions. Kristina Burow's most active month to dispose stocks was the month of July. 2023 saw Kristina Burow paying a total of $0.00 for 166,943 shares, this is the most they've acquired in one year. In 2015 Kristina Burow cashed out on 53,946 shares for a total of $5,931,588.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sana Biotechnology, Inc. (SANA) Snapshot price: $5.05

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+5.39%
1.82M
$5.50
$9,999,995.50
35.56M
Feb 8
Form 4
+14,957.26%
43.75M
—
—
44.04M
Feb 8
Form 3
—
0
—
—
0
No matching records found

Erasca, Inc. (ERAS) Snapshot price: $2.86

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
11.06M
—
—
11.06M
Jul 20
Form 3
—
0
—
—
0
No matching records found

Verve Therapeutics, Inc. (VERV) Snapshot price: $5.595

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.51M
—
—
2.51M
Jun 21
Form 3
—
0
—
—
0
No matching records found

Prime Medicine, Inc. (PRME) Snapshot price: $3.4303

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.2M
$6.25
$20,000,000.00
3.2M
Feb 15
Form 4
∞
12.26M
$17.00
—
12.26M
Oct 24
Form 3
—
0
—
—
0
No matching records found

Rapport Therapeutics, Inc. No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.73M
—
—
3.73M
Jun 10
Form 3
—
0
—
—
0
No matching records found